Organisation paid for research Program year 2025 Source: CMS Open Payments

Carrot Eye Center

Neither a doctor nor a teaching hospital

Research payments

$178,513

13 payments

Through program year 2025, Carrot Eye Center is reported as receiving $178,513 in research payments, across 13 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $59,139 11
2021 Research $111,878 1
2020 Research $7,496 1

Breakdown

Who paid Research payments · program years 2020–2025
  1. Novartis Pharmaceuticals Corporation $119,374 2 payments
  2. Oyster Point Pharma, Inc. $59,139 11 payments
Studies the money was for Research payments · program years 2020–2025
  1. A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of Ecf843 VS Vehicle in Subjects With Dry Eye Disease $119,374 2 payments
  2. Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) $55,086 10 payments
  3. Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) $4,053 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record